Patient Participation

Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.

Minimizing protocol deviations is a simple, yet effective way for sites to keep trials patient-centric.

A three-part framework for a more comprehensive conceptual model of patient experience data can provide a more rounded understanding of patient experiences in clinical trials and beyond.

Webinar Date/Time: Wed, Jul 17, 2024 1:00 PM EDT

How making trial participation easier can reduce the impact on the environment.

New research updates estimated value of lost time.

Nine tips to help sites close the information and understanding gaps in their dealings with patients.

In part 1 of this video interview, Sam Liu, VP of marketing, Vivalink touches on concerns with data accuracy and security in bring-your-own-device models.

A more user-centered design can allow increased flexibility in the development of eCOA platforms, driving better engagement and participation.

A forum of prominent industry stakeholders highlights the challenges for patients in navigating the multiple legal, regulatory, and ethical barriers to cross-border participation.

Survey study assessed 58 cancer centers in the United States to identify their greatest challenges.

Webinar Date/Time: Thursday, June 6, 2024 Session 1: 9am EDT | 6am PDT | 2pm BST | 3pm CEST Session 2: 1pm EDT | 10am PDT | 6pm BST | 7pm CEST

Analysis of randomized clinical trial for migraine sought to determine whether there were differences between outcomes from patients assigned to roles and those as healthy controls.

In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.

Harnessing advances in digital health technologies for a more precision-measured approach.

The potential of personal health records to bridge the gap between research and care.

Five proactive steps industry can take to optimize a patient's clinical trial experience.

Following a webinar on the use of a medical device in a migraine clinical trial, Mowlem caught up with ACT to discuss her biggest takeaways and what she is currently seeing in the digital trials space.

Systematic review of research articles sought to identify and characterize different technologies being used in clinical studies.

Webinar Date/Time: Tuesday, April 30, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.

Results of cross-sectional study of 50 discharge summaries suggest a large language model can be used to increase their understandability.

In light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, talks about the ethical considerations that need to be addressed when implementing new technologies for collecting and analyzing patient data in clinical trials, while ensuring patient privacy.

In this Applied Clinical Trials video interview, Julia Lakeland, Chief Product Officer, uMotif, discusses new technologies that can help personalize the clinical trial experience for diverse patient populations.